Breaking Manchester City Extends Perfect Start with 1-0 Victory Over Coventry U.S. Ambassador Labels Israeli Settler Violence ‘Terrorism’ Drone Attack and Clash in Northeastern Colombia Kills Three Soldiers, Wounds Four Kamila Valieva Barred from International Competition as Neutral Athlete US Economy Shows Mixed Signals: August Sees Hiring Rebound Amidst Rising Mortgage Rates

Saturday September 5, 2026

Reporter

Teva Pharmaceutical Industries Ltd

8Articles Published

4Communities Covered

Published Articles

Press Release

S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

Sep 4

Press Release

Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential

Sep 2

Press Release

Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September

Sep 1

Press Release

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

Aug 31

Press Release

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

Aug 28

Press Release

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Aug 19

Press Release

Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy

Aug 11

Press Release

Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy

Jul 29